Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2

Polina A Egorova1, Ilya B Bezprozvanny2,3

  • 1Laboratory of Molecular Neurodegeneration, Peter the Great St.Petersburg Polytechnic University, St. Petersburg, 195251, Russia.

Insights

Effective treatments for spinocerebellar ataxia type 2 (SCA2) are unavailable. This review discusses recent progress in understanding SCA2 molecular mechanisms to develop potential therapies and therapeutic targets.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Spinocerebellar ataxia type 2 (SCA2) is a progressive hereditary neurodegenerative disease.
  • It is caused by polyglutamine expansion in the ataxin-2 protein.
  • Currently, only symptomatic treatments and palliative care are available for SCA2 patients.

Purpose of the Study:

  • To review recent progress in understanding the molecular mechanisms of SCA2.
  • To discuss potential therapeutic targets and strategies for SCA2 treatment.
  • To highlight promising therapeutic approaches for SCA2.

Main Methods:

  • Review of existing literature on SCA2.
  • Analysis of physiological, molecular, and biochemical changes in SCA2 patients and model systems.
  • Discussion of emerging therapeutic strategies based on molecular insights.

Main Results:

  • Understanding SCA2's molecular mechanisms has advanced significantly.
  • Several promising therapeutic strategies and targets have been identified.
  • Progress has been made in developing potential disease-modifying therapies.

Conclusions:

  • Despite current limitations in effective treatment, research is yielding promising therapeutic avenues for SCA2.
  • Further investigation into molecular mechanisms is crucial for developing disease-modifying therapies.
  • The review highlights recent advancements and future directions in SCA2 therapeutic development.

Related Concept Videos

SN2 Reaction: Mechanism02:27

SN2 Reaction: Mechanism

The kinetic studies of SN2 reactions suggest an essential feature of its mechanism: it is a single-step process without intermediates. Here, both the nucleophile and the substrate participate in the rate-determining step.
The presence of the more electronegative halogen in the substrate creates a polarized carbon-halide bond. The halide pulls the electron cloud generating an electrophilic center at the carbon atom. Thus, the carbon atom carries a partial positive charge while the halide has a...
17.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K